Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Use this FENC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FENC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FENC SEC filings page. Lician reads the product cache first so this HTML stays unique to Fennec Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FENC income, balance, and cash tables.